Page 1 of Clinical Trials for PDE5 inhibitor, 417 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone
Last Updated: August 22, 2008
Condition(s): Erectile Dysfunction; Hypogonadism
2
Recruiting
PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Last Updated: May 8, 2012
Condition(s): Anterior Ischemic Optic Neuropathy
3
Recruiting
A Study to Determine if There is a Possible Association Between Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) and Phosphodiesterase Type 5 (PDE5) Inhibitors
Last Updated: March 26, 2012
Condition(s): Nonarteritic Anterior Ischemic Optic Neuropathy
4
Completed
The Effect of CYP3A Genetic Polymorphism on the Pharmacokinetics of Phosphodiesterase type5 Inhibitors in Male Subjects
Last Updated: October 6, 2008
Condition(s): Pharmacokinetics of Three PDE5Is; Healthy Subjects; Genetic Polymorphic CYP3A5
5
Completed
Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension
Last Updated: March 20, 2012
Condition(s): Pulmonary Arterial Hypertension
6
Recruiting
Low Intensity Shock Wave Therapy (LI-ESWT) for Erectile Dysfunction in Post Radical Prostatectomy Patients Not Responding to PDE5 Inhibitors (LI-ESWT)
Last Updated: May 23, 2012
Condition(s): Erectile Dysfunction
7
Not yet recruiting
Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration
Last Updated: March 28, 2012
Condition(s): Diabetic Nephropathy; Chronic Kidney Disease
8
Completed
An Efficacy and Safety Study of Dapoxetine in Men With Premature Ejaculation and Concomitant Erectile Dysfunction Treated With a Phosphodiesterase-5 Inhibitor (ie, Sildenafil, Vardenafil, or Tadalafil)
Last Updated: April 26, 2012
Condition(s): Erectile Dysfunction; Sexual Dysfunction
9
Recruiting
A Study to Assess Whether PDE5 Inhibitors Increase the Chance of Triggering the Onset of Acute NAION
Last Updated: May 22, 2012
Condition(s): Optic Neuropathy, Ischemic
10
Completed
Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor
Last Updated: April 3, 2012
Condition(s): Erectile Dysfunction; Cardiovascular Diseases; Male Urogenital Diseases
11
Completed
Phosphodiesterase-5 Inhibitor in Eisenmenger Syndrome
Last Updated: September 13, 2010
Condition(s): Eisenmenger Syndrome
12
Completed
A Randomised Study of Levitra to Treat Men With Erections Problems and Previously Untreated With Similar Therapy.
Last Updated: June 29, 2009
Condition(s): Erectile Dysfunction
13
Completed
Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors
Last Updated: February 2, 2010
Condition(s): Hypogonadism; Erectile Dysfunction
14
Withdrawn
A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 Inhibitor
Last Updated: May 10, 2012
Condition(s): Pulmonary Arterial Hypertension
15
Recruiting
Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon
Last Updated: January 28, 2011
Condition(s): Raynaud Phenomenon
16
Completed
Pelvic Angiography in Non-Responders to Phosphodiesterase-5 Inhibitors (PANPI)
Last Updated: March 25, 2008
Condition(s): Erectile Dysfunction
17
Not yet recruiting
Nephroprotective Effects of Carnitine and (PDE5) Inhibitor Agent Against Contrast Media-induced Nephropathy (CMN)
Last Updated: March 24, 2012
Condition(s): Contrast Media Induced Nephropathy
18
Completed
The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Last Updated: May 14, 2012
Condition(s): Hypogonadism; Erectile Dysfunction
19
Completed
Clinical Proof-of-concept Study for the Combination BAY60-4552 / Vardenafil for the Treatment of Erectile Dysfunction Not Sufficiently Responsive to Standard Therapy With PDE5 Inhibitors
Last Updated: May 16, 2012
Condition(s): Erectile Dysfunction
20
Recruiting
Study of Incidence of Respiratory Tract Adverse Events in Patients Treated With Tyvaso® Compared to Other FDA Approved Pulmonary Arterial Hypertension (PAH) Therapies
Last Updated: January 11, 2012
Condition(s): Pulmonary Arterial Hypertension

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=PDE5+inhibitor

Page 1 of Clinical Trials for PDE5 inhibitor, 417 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About